SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 353 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $22,000 | -4.3% | 300 | 0.0% | 0.01% | +14.3% |
| Q1 2022 | $23,000 | -14.8% | 300 | 0.0% | 0.01% | -12.5% |
| Q4 2021 | $27,000 | -3.6% | 300 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $28,000 | +21.7% | 300 | 0.0% | 0.01% | +14.3% |
| Q2 2021 | $23,000 | +4.5% | 300 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $22,000 | -56.9% | 300 | 0.0% | 0.01% | -58.8% |
| Q4 2020 | $51,000 | +21.4% | 300 | 0.0% | 0.02% | +6.2% |
| Q3 2020 | $42,000 | -12.5% | 300 | 0.0% | 0.02% | -20.0% |
| Q2 2020 | $48,000 | +65.5% | 300 | 0.0% | 0.02% | +33.3% |
| Q1 2020 | $29,000 | -23.7% | 300 | 0.0% | 0.02% | -11.8% |
| Q4 2019 | $38,000 | +65.2% | 300 | 0.0% | 0.02% | +41.7% |
| Q3 2019 | $23,000 | -50.0% | 300 | 0.0% | 0.01% | -50.0% |
| Q2 2019 | $46,000 | -23.3% | 300 | -40.0% | 0.02% | -22.6% |
| Q1 2019 | $60,000 | +11.1% | 500 | 0.0% | 0.03% | -3.1% |
| Q4 2018 | $54,000 | -33.3% | 500 | 0.0% | 0.03% | -25.6% |
| Q3 2018 | $81,000 | – | 500 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 87,180 | $2,581,000 | 3.60% |
| Perceptive Advisors | 1,771,029 | $52,422,000 | 2.99% |
| SPHERA FUNDS MANAGEMENT LTD. | 483,047 | $14,298,000 | 2.80% |
| HealthCor Management, L.P. | 1,550,000 | $45,880,000 | 2.10% |
| Camber Capital Management LP | 1,350,000 | $39,960,000 | 1.62% |
| Tourbillon Capital Partners, L.P. | 1,537,518 | $45,511,000 | 1.17% |
| Elk Creek Partners, LLC | 562,522 | $16,651,000 | 1.02% |
| EMERALD ADVISERS, LLC | 818,705 | $24,234,000 | 1.00% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 604,467 | $17,892,000 | 0.82% |
| Carlson Capital, L.P. | 1,845,702 | $54,633,000 | 0.70% |